Finanza

Notizie Idee Discussioni Tecnici Previsione Stagionalità Opzioni

Totale attività su Immunovant, Inc..

Dati annuali

2019

2020

2021

2022

2023

‪0,00‬

‪‪170,00 M‬‬

‪‪340,00 M‬‬

‪‪510,00 M‬‬

‪‪680,00 M‬‬

Periodo

Valore

Variazione

Variazione %

2023

‪‪666,71 M‬‬

+‪‪260,87 M‬‬

+‪64,28‬%

2022

‪‪405,84 M‬‬

‪‪−109,73 M‬‬

‪−21,28‬%

2021

‪‪515,56 M‬‬

+‪‪103,07 M‬‬

+‪24,99‬%

2020

‪‪412,49 M‬‬

+‪‪303,10 M‬‬

+‪277,09‬%

2019

‪‪109,39 M‬‬

+‪‪108,98 M‬‬

+‪‪26,91 K‬‬%

Dati trimestrali

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪200,00 M‬‬

‪‪400,00 M‬‬

‪‪600,00 M‬‬

‪‪800,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪420,93 M‬‬

‪‪−94,78 M‬‬

‪−18,38‬%

Q2 '24

‪‪515,71 M‬‬

‪‪−73,97 M‬‬

‪−12,54‬%

Q1 '24

‪‪589,68 M‬‬

‪‪−77,03 M‬‬

‪−11,55‬%

Q4 '23

‪‪666,71 M‬‬

‪‪−44,73 M‬‬

‪−6,29‬%

Q3 '23

‪‪711,45 M‬‬

+‪‪419,38 M‬‬

+‪143,59‬%

Q2 '23

‪‪292,07 M‬‬

‪‪−59,15 M‬‬

‪−16,84‬%

Q1 '23

‪‪351,22 M‬‬

‪‪−54,62 M‬‬

‪−13,46‬%

Q4 '22

‪‪405,84 M‬‬

‪‪−50,41 M‬‬

‪−11,05‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19